This prompted yet another study which showed that deaths from cancers were higher for sufferers who received three or more prescriptions for treatment with Regranex than those who were not treated with Regranex – no specific type of cancer was identified, but instead deaths from all types of cancer, combined were observed. The FDA recommends that Regranex be utilized only when the huge benefits should be expected to outweigh the risks.. Cancer warning on diabetic ulcer gel The U.S. Watchdog the Food and Medication Administration says a warning will be put into the label of a topical gel used to take care of leg and feet ulcers which won’t heal in diabetic patients.The researchers are evaluating the result of erlotinib on EGFR expression on bladder tumor cells at the molecular level. Ultimately, they’ll pursue a stage III clinical trial for his or her research, ‘where in fact the drug can be examined by us in bigger numbers of sufferers and compare its results to randomized controls,’ she explained. ‘Bladder cancers could be a deadly disease, even though you catch it early apparently. Once it spreads, sufferers usually do not fare well. So if the medication can limit the pass on of disease before cystectomy, if patients could be down-staged or possess organ-confined disease at the proper time of cystectomy, their likelihood of survival rise dramatically.